CD8A and neoplasm: When mice were sacrificed on day 28 post B16F10 tumor inoculation, analysis of angiogenesis at that time point clearly suggested a predominant role for CD8+ T cells in NLGP driven immune-mediated vascular normalization, since CD8+ T cell depletion completely abolished anti-angiogenic potential of NLGP pretreatment (Figure 4C).